Evidence map›Paper›PMID 36416459›Full record

ArticleJournal of clinical research in pediatric endocrinology2024

A New Variant of the

Elif Söbü, Gül Demet Kaya Özçora, Elif Yılmaz Güleç, Bahtiyar Şahinoğlu, Feride Tahmiscioğlu Bucak

Open access · goldAbstract readCase Reports
In one paragraph

Article in Journal of clinical research in pediatric endocrinology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Essential requirement for IER3IP1 in B cell development.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 2 countries.

Elif SöbüKartal Dr. Lütfi Kırdar City Hospital, Clinic of Pediatric Endocrinology, İstanbul, TurkeyORCID 0000-0002-2037-7046
Gül Demet Kaya ÖzçoraHasan Kalyoncu University Faculty of Medical Sciences, Department of Pediatric Neurology, Gaziantep, TurkeyORCID 0000-0003-3316-8654
Elif Yılmaz Güleçİstanbul Medeniyet University Faculty of Medicine, Göztepe Prof. Dr. Süleyman Yalçın City Hospital, Clinic of Medical Genetics, İstanbul, TurkeyORCID 0000-0003-0872-3898
Bahtiyar ŞahinoğluDr. Ersin Arslan Training and Research Hospital, Clinic of Medical Genetics, Gaziantep, TurkeyORCID 0000-0002-2208-540X
Feride Tahmiscioğlu BucakBağcılar Training and Research Hospital, Clinic of Pediatric Endocrinology, İstanbul, TurkeyORCID 0000-0001-6239-6395
Dr Lütfi Kırdar Kartal Eğitim ve Araştırma Hastanesi · TRHasan Kalyoncu University · TRIstanbul Medeniyet University · TRMedical Park Gaziantep Hospital · TRMinistry of Health · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microcephaly, epilepsy and diabetes syndrome 1 (MEDS1) is a rare autosomal recessive disorder caused by defects in the immediate early response 3 interacting protein 1 (

Indexed as

EpilepsyMicrocephalyCarrier ProteinsDiabetes MellitusFemaleHumansInfantMaleMembrane ProteinsTurkeyCarrier ProteinsIER3IP1 protein, humanMembrane ProteinsDevelopmental delaydiabetes mellitusepilepsyIER3IP1MEDS1

Identifiers

PMID36416459
PMCPMC11590771
OpenAlexW4309834019

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.